Navigation Links
Isis Reports Financial Results and Highlights for Fiscal year 2007
Date:3/13/2008

by Isis and Isis' partners, the Company anticipates many clinical events for 2008; some are highlighted below:
* Isis' cardiovascular franchise will continue to provide clinical

evidence to support the activity and safety profiles of

second-generation antisense drugs. Isis completed two key goals

early, including the licensing of mipomersen, the lead drug in this

franchise, to Genzyme and the initiation of Phase 3 studies of

mipomersen in patients with Familial Hypercholesterolemia.

* Over the upcoming months, Isis expects to effect a seamless

transition of mipomersen development to Genzyme.

* Isis and Genzyme expect to report new safety data for

mipomersen.

* Isis expects to initiate Phase 1 clinical studies of ISIS

353512 that targets CRP for the treatment of coronary artery

disease.

* Isis and BMS expect to advance into development a drug

targeting PCSK9 for the treatment of cardiovascular disease.

* Isis' metabolic franchise, which consists of four novel and

complementary drugs to treat type 2 diabetes, will continue to grow,

with clinical data expected from the most advanced of the four drugs,

ISIS 113715, and Isis will continue to explore the therapeutic

opportunities for antisense drugs to treat obesity.

* Isis expects to report Phase 2 study data in Type 2 diabetics

treated with ISIS 113715 and sulfonylureas.

* Isis expects to complete the Phase 1 study of ISIS 325568, an

antisense drug licensed to OMI that targets GCGR to treat

diabetes. Isis expects OMI will choose to initiate Phase 2

studies of ISIS 325568 in patients with type 2 diabetes.

* Isis' partners developing antisense drugs
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... 03, 2015 , ... Since 1978, the number of black males applying to ... released today by the AAMC (Association of American Medical Colleges). , Despite an ... decades, the number of black male applicants to medical school dropped to 1,337 in ...
(Date:8/3/2015)... Angeles, CA (PRWEB) , ... August 03, 2015 , ... According to an opinion ... calories out of person’s diet leads to one pound of weight loss may not be ... caloric reduction that translates to one pound of fat varies – based both on the ...
(Date:8/3/2015)... ... August 03, 2015 , ... BESLER Consulting today announced the ... , The MarketingProfs Bright Bulb B2B Awards celebrate the best marketing, communications, and ... launch of their Readmissions Analytics product was selected as one of four finalists ...
(Date:8/3/2015)... ... August 03, 2015 , ... A ... while an overwhelming number of Hispanics believe people can positively affect their diabetes, ... of participants queried said making diet changes was important. Far fewer participants mentioned ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... and amputation , AUGUST 3, 2015 – Since winning a South by Southwest® ... Not Impossible – an organization whose mission is to develop technology for the ...
Breaking Medicine News(10 mins):Health News:New Publication Focuses on the Decline of Black Males in Medicine 2Health News:New Publication Focuses on the Decline of Black Males in Medicine 3Health News:New Publication Focuses on the Decline of Black Males in Medicine 4Health News:Article Dispelling Weight Loss Myth Correctly Emphasizes the Complicated and Difficult Nature of Weight Loss, Says Dr. Michael Feiz 2Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 2Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 4Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 2Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 4
... Genetic factors may be at play when it comes ... and vulnerability for depression// , according to a new ... the October issue of the journal Archives of General ... genetic analyses that showed that neuroticism is a strong ...
... Ooteman a Dutch researcher has stumbled upon some very ... of understanding// the biological and genetic characteristics of alcoholics, ... curb the irresistible urge to drink. ,The urge ... like Naltrexone and Acamprosate. The investigations done by the ...
... focus on U.S. soldiers seriously wounded or injured during ... //severity may predict the risk for posttraumatic stress disorder ... 2006 issue of The American Journal of Psychiatry, the ... study written by Thomas A. Grieger, M.D., and colleagues ...
... Manchester Been honored with a prized award for research ... suffer from chronic or acute back pain worldwide. ... Student annually at the Science, Engineering and Technology Student ... Ambury. ,She examined how special ‘Braces’ or ...
... immigration detention centers has been accused of providing inadequate ... the prison watchdog.// ,Chief Inspector of Prisons ... Wood Immigration Removal Centre in Bedfordshire following concerns raised ... Uganda. ,Although Owers praised the work of ...
... research reported that ragweed or hay fever symptoms could be ... vaccine developed at Johns Hopkins in Baltimore. ,Dr. ... and Allergy Center at the Johns Hopkins University School of ... fall ragweed seasons in Baltimore. ,The study was ...
Cached Medicine News:Health News:Link Between Neuroticism and Depression May be Genetic 2Health News:DNA vaccine for ragweed allergies 2
(Date:8/3/2015)... Pa. , Aug. 3, 2015 VWR ... laboratory products, services and solutions, announces the redesign of its ... customers. When visiting the new site, guests ... with bold colors and vivid images.  Each country site now ... an A to Z product menu; and , the ...
(Date:8/3/2015)... SPRINGS, Florida , August 3, 2015 /PRNewswire/ ... HOLD -- FN Media Group LLC, PIV757417 The ... Focus on Developing Orphan Drug Products & Treatments ... now OFF HOLD. Distribution time: 3 Aug 2015 ... agreements between biotech companies, military surgical research and ...
(Date:8/3/2015)... 2015  Charleston Laboratories, Inc., an emerging specialty ... development program with a Phase 1 study on ... CL-H1T contains fast-dissolving promethazine and sumatriptan.  This novel ... for migraine headache pain and migraine-induced nausea and ... migraine headaches also suffer from nausea and vomiting," ...
Breaking Medicine Technology:VWR's New Website Redesign Provides Improved Functionality for Customers 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 3/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 4/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 5/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 6Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2
... , AUSTIN, Texas, Dec. 9 Ascension ... recent hiring of two veteran executives, L. Robert Johnston, Jr. ... Vice President of Marketing. "These individuals bring a wealth of ... future growth of Ascension," said Guy Mayer, CEO. "As members ...
... Dec. 9 BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) ... to the Company,s Board of Directors. Dr. Sanders brings ... physician and professor of medicine. , "We are ... said Zola P. Horovitz, Ph.D., Chairman of the Board of ...
Cached Medicine Technology:Ascension Orthopedics Hires Key Senior Executives 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4
... Designed for High Throughput Screening (HTS), ... assays into HTS by sharing all ... of Analyst AD, fluorescence intensity, fluorescence ... Optimized for seamless integration into robotic ...
... for cell-based assays, the NOVOstar provides both ... the flexibility of an on-board reagent pipet. ... to plate or from three reagent stations ... unit has two injectors that can accurately ...
... High sensitivity and ... for eight different radiometric ... first system with true ... radiometric assays, by exploiting ...
This a new dedicated VICTOR2 model for fluorescence, fluorescence polarization and luminescence measurement with stacker and robotic loading....
Medicine Products: